NHS B12 therapy is evidence-based for documented deficiency, using hydroxocobalamin 1mg intramuscularly with standardised protocols
Future evidence may highlight specific populations, not yet covered by guidance, who may benefit from taking them. For food and beverage, this will create challenges as well as opportunities but staying across the science is essential for exploiting them
This suggests that GLP-1 action on L-cells is mediated through paracrine and/or neuronal signals
The beyond-use date ranges from 30 to 90 days, and tablets should never be split or cut
consult a healthcare professional for skin conditions
Youll likely start at 2.5 mg and go up slowly, usually once every 4 weeks, until you reach your maintenance dosage, up to a maximum maintenance dosage of 15 mg weekly